Discovery of an antitumor compound from xenorhabdus stockiae HN_xs01
World Journal of Microbiology and Biotechnology · 2024
DOI: 10.1007/s11274-024-03915-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Microbiology and Biotechnology, 2024. Verfasst von Xiyin Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Developmental Biology of Freshwater Fish, Hunan Provincial Key Laboratory of Microbial Molecular Biology, College of Life Sci…. Hauptthemen laut MEDLINE: Xenorhabdus, Nematoda. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Research Foundation of Education Bureau of Hunan Province.
Abstract (Originalsprache)
Xenorhabdus, known for its symbiotic relationship with Entomopathogenic nematodes (EPNs), belongs to the Enterobacteriaceae family. This dual-host symbiotic nematode exhibits pathogenic traits, rendering it a promising biocontrol agent against insects. Our prior investigations revealed that Xenorhabdus stockiae HN_xs01, isolated in our laboratory, demonstrates exceptional potential in halting bacterial growth and displaying anti-tumor activity. Subsequently, we separated and purified the supernatant of the HN_xs01 strain and obtained a new compound with significant inhibitory activity on tumor cells, which we named XNAE. Through LC-MS analysis, the mass-to-nucleus ratio of XNAE was determined to be 254.24. Our findings indicated that XNAE exerts a time- and dose-dependent inhibition on B16 and HeLa cells. After 24 h, its IC50 for B16 and HeLa cells was 30.178 µg/mL and 33.015 µg/mL, respectively. Electron microscopy revealed conspicuous damage to subcellular structures, notably mitochondria and the cytoskeleton, resulting in a notable reduction in cell numbers among treated tumor cells. Interestingly, while XNAE exerted a more pronounced inhibitory effect on B16 cells compared to HeLa cells, it showed no discernible impact on HUVEC cells. Treatment of B16 cells with XNAE induced early apoptosis and led to cell cycle arrest in the G2 phase, as evidenced by flow cytometry analysis. The impressive capability of X. stockiae HN_xs01 in synthesizing bioactive secondary metabolites promises to significantly expand the reservoir of natural products. Further exploration to identify the bioactivity of these compounds holds the potential to shed light on their roles in bacteria-host interaction. Overall, these outcomes underscore the promising potential of XNAE as a bioactive compound for tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Developmental Biology of Freshwater Fish, Hunan Provincial Key Laboratory of Microbial Molecular Biology, College of Life Science, Hunan Normal University, No.36 Lushan Street, Changsha, 410081,…
Förderung
- National Natural Science Foundation of China
- Research Foundation of Education Bureau of Hunan Province
Zitieren
APA
Huang, X., Tang, Q., Liu, S., Li, C., Li, Y., Sun, Y., Ding, X., Xia, L., & Hu, S. (2024). Discovery of an antitumor compound from xenorhabdus stockiae HN_xs01. World Journal of Microbiology and Biotechnology. https://doi.org/10.1007/s11274-024-03915-1
Vancouver
Huang X, Tang Q, Liu S, Li C, Li Y, Sun Y, et al. Discovery of an antitumor compound from xenorhabdus stockiae HN_xs01. World Journal of Microbiology and Biotechnology. 2024. doi:10.1007/s11274-024-03915-1
BibTeX
@article{Huang2024,
author = {Huang, Xiyin and Tang, Qiong and Liu, Siqin and Li, Chen and Li, Yaoguang and Sun, Yunjun and Ding, Xuezhi and Xia, Liqiu and Hu, Shengbiao},
title = {Discovery of an antitumor compound from xenorhabdus stockiae HN_xs01},
journal = {World Journal of Microbiology and Biotechnology},
year = {2024},
doi = {10.1007/s11274-024-03915-1}
}
EUVIMED